 | • レポートコード：MRC2-11QY11189 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は画期的治療薬のグローバル市場について調査・分析したレポートです。種類別（腫瘍、抗ウイルス剤、神経、その他）市場規模、用途別（病院、クリニック、外来サービス）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別画期的治療薬の競争状況、市場シェア ・世界の画期的治療薬市場：種類別市場規模 2015年-2020年（腫瘍、抗ウイルス剤、神経、その他） ・世界の画期的治療薬市場：種類別市場規模予測 2021年-2026年（腫瘍、抗ウイルス剤、神経、その他） ・世界の画期的治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、外来サービス） ・世界の画期的治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来サービス） ・北米の画期的治療薬市場分析：米国、カナダ ・ヨーロッパの画期的治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの画期的治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の画期的治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの画期的治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Pfizer、AbbVie、Bristol-Myers Squibb Company、Genentech、Gilead、Novartis、Vertex Pharmaceuticals Incorporated ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two factors determine the efficiency of breakthrough therapy drug, they are the magnitude of the treatment effect and observed clinical difference over the existed drug. The standard for breakthrough therapy drug is not same as standard drug approval because, in breakthrough therapy, morbidity and mortality considered for approval of the drug. They are meant to be administered by itself or in combinations. Breakthrough therapy drug development is cost effective due to faster approval of drugs on limited data from the FDA. Manufacturer of breakthrough therapy drugs has to develop additional post-marketing surveillance data for the other reimbursements and market access. Presently available breakthrough therapy medicinal products in the market belong to the treatment class of oncology, infectious diseases, cardiovascular conditions, etc. The designation is given when the drug is in 1st or 2nd stage of clinical trials.
Increasing prevalence of life-threatening conditions and for the speedy development of pipeline drugs is the primary driver for the breakthrough therapy drugs market. This is because of the high unmet need of presently available treatment for severe conditions. Breakthrough designation of the drug captures the more attention of the manufacturers due to the expedited market access and greater returns on their investments. Because of Breakthrough therapy drugs market are associated with less robust clinical developments. Increasing support of FDA for small scale industries in R&D by providing additional funding and faster approval of drugs fuelling the growth of the breakthrough therapy drugs market. All these factors are boosting the growth of the breakthrough therapy drug market.
Market Analysis and Insights: Global Breakthrough Therapy Drugs Market
The global Breakthrough Therapy Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Breakthrough Therapy Drugs Scope and Market Size
Breakthrough Therapy Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breakthrough Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Pfizer
AbbVie
Bristol-Myers Squibb Company
Genentech
Gilead
Novartis
Vertex Pharmaceuticals Incorporated
Market segment by Type, the product can be split into
Oncology
Anti-Viral
Neurology
Others
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Services
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breakthrough Therapy Drugs Revenue
1.4 Market by Type
1.4.1 Global Breakthrough Therapy Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 Anti-Viral
1.4.4 Neurology
1.4.5 Others
1.5 Market by Application
1.5.1 Global Breakthrough Therapy Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Services
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Breakthrough Therapy Drugs Market Perspective (2015-2026)
2.2 Global Breakthrough Therapy Drugs Growth Trends by Regions
2.2.1 Breakthrough Therapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Breakthrough Therapy Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Breakthrough Therapy Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Breakthrough Therapy Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Breakthrough Therapy Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Breakthrough Therapy Drugs Players by Market Size
3.1.1 Global Top Breakthrough Therapy Drugs Players by Revenue (2015-2020)
3.1.2 Global Breakthrough Therapy Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Breakthrough Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breakthrough Therapy Drugs Market Concentration Ratio
3.2.1 Global Breakthrough Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Breakthrough Therapy Drugs Revenue in 2019
3.3 Breakthrough Therapy Drugs Key Players Head office and Area Served
3.4 Key Players Breakthrough Therapy Drugs Product Solution and Service
3.5 Date of Enter into Breakthrough Therapy Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Breakthrough Therapy Drugs Historic Market Size by Type (2015-2020)
4.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Breakthrough Therapy Drugs Market Size by Application (2015-2020)
5.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Breakthrough Therapy Drugs Market Size (2015-2020)
6.2 Breakthrough Therapy Drugs Key Players in North America (2019-2020)
6.3 North America Breakthrough Therapy Drugs Market Size by Type (2015-2020)
6.4 North America Breakthrough Therapy Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Breakthrough Therapy Drugs Market Size (2015-2020)
7.2 Breakthrough Therapy Drugs Key Players in Europe (2019-2020)
7.3 Europe Breakthrough Therapy Drugs Market Size by Type (2015-2020)
7.4 Europe Breakthrough Therapy Drugs Market Size by Application (2015-2020)
8 China
8.1 China Breakthrough Therapy Drugs Market Size (2015-2020)
8.2 Breakthrough Therapy Drugs Key Players in China (2019-2020)
8.3 China Breakthrough Therapy Drugs Market Size by Type (2015-2020)
8.4 China Breakthrough Therapy Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Breakthrough Therapy Drugs Market Size (2015-2020)
9.2 Breakthrough Therapy Drugs Key Players in Japan (2019-2020)
9.3 Japan Breakthrough Therapy Drugs Market Size by Type (2015-2020)
9.4 Japan Breakthrough Therapy Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Breakthrough Therapy Drugs Market Size (2015-2020)
10.2 Breakthrough Therapy Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Breakthrough Therapy Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Breakthrough Therapy Drugs Market Size by Application (2015-2020)
11 India
11.1 India Breakthrough Therapy Drugs Market Size (2015-2020)
11.2 Breakthrough Therapy Drugs Key Players in India (2019-2020)
11.3 India Breakthrough Therapy Drugs Market Size by Type (2015-2020)
11.4 India Breakthrough Therapy Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Breakthrough Therapy Drugs Market Size (2015-2020)
12.2 Breakthrough Therapy Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Breakthrough Therapy Drugs Market Size by Type (2015-2020)
12.4 Central & South America Breakthrough Therapy Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Breakthrough Therapy Drugs Introduction
13.1.4 Merck Revenue in Breakthrough Therapy Drugs Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Breakthrough Therapy Drugs Introduction
13.2.4 Pfizer Revenue in Breakthrough Therapy Drugs Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview
13.3.3 AbbVie Breakthrough Therapy Drugs Introduction
13.3.4 AbbVie Revenue in Breakthrough Therapy Drugs Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Details
13.4.2 Bristol-Myers Squibb Company Business Overview
13.4.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Introduction
13.4.4 Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2015-2020)
13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Genentech
13.5.1 Genentech Company Details
13.5.2 Genentech Business Overview
13.5.3 Genentech Breakthrough Therapy Drugs Introduction
13.5.4 Genentech Revenue in Breakthrough Therapy Drugs Business (2015-2020)
13.5.5 Genentech Recent Development
13.6 Gilead
13.6.1 Gilead Company Details
13.6.2 Gilead Business Overview
13.6.3 Gilead Breakthrough Therapy Drugs Introduction
13.6.4 Gilead Revenue in Breakthrough Therapy Drugs Business (2015-2020)
13.6.5 Gilead Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Breakthrough Therapy Drugs Introduction
13.7.4 Novartis Revenue in Breakthrough Therapy Drugs Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Vertex Pharmaceuticals Incorporated
13.8.1 Vertex Pharmaceuticals Incorporated Company Details
13.8.2 Vertex Pharmaceuticals Incorporated Business Overview
13.8.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Introduction
13.8.4 Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2015-2020)
13.8.5 Vertex Pharmaceuticals Incorporated Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Breakthrough Therapy Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Breakthrough Therapy Drugs Revenue
Table 3. Ranking of Global Top Breakthrough Therapy Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breakthrough Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncology
Table 6. Key Players of Anti-Viral
Table 7. Key Players of Neurology
Table 8. Key Players of Others
Table 9. Global Breakthrough Therapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Breakthrough Therapy Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Breakthrough Therapy Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Breakthrough Therapy Drugs Market Share by Regions (2015-2020)
Table 13. Global Breakthrough Therapy Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Breakthrough Therapy Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Breakthrough Therapy Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Breakthrough Therapy Drugs Players
Table 20. Global Breakthrough Therapy Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Breakthrough Therapy Drugs Market Share by Players (2015-2020)
Table 22. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy Drugs as of 2019)
Table 23. Global Breakthrough Therapy Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Breakthrough Therapy Drugs Product Solution and Service
Table 26. Date of Enter into Breakthrough Therapy Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Breakthrough Therapy Drugs Market Size Share by Type (2015-2020)
Table 30. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Breakthrough Therapy Drugs Market Size Share by Application (2015-2020)
Table 32. Global Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Breakthrough Therapy Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Breakthrough Therapy Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Breakthrough Therapy Drugs Market Share (2019-2020)
Table 36. North America Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Breakthrough Therapy Drugs Market Share by Type (2015-2020)
Table 38. North America Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Breakthrough Therapy Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Breakthrough Therapy Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Breakthrough Therapy Drugs Market Share (2019-2020)
Table 42. Europe Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Breakthrough Therapy Drugs Market Share by Type (2015-2020)
Table 44. Europe Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Breakthrough Therapy Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Breakthrough Therapy Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Breakthrough Therapy Drugs Market Share (2019-2020)
Table 48. China Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Breakthrough Therapy Drugs Market Share by Type (2015-2020)
Table 50. China Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Breakthrough Therapy Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Breakthrough Therapy Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Breakthrough Therapy Drugs Market Share (2019-2020)
Table 54. Japan Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Breakthrough Therapy Drugs Market Share by Type (2015-2020)
Table 56. Japan Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Breakthrough Therapy Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Breakthrough Therapy Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Breakthrough Therapy Drugs Market Share (2019-2020)
Table 60. Southeast Asia Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Breakthrough Therapy Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Breakthrough Therapy Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Breakthrough Therapy Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Breakthrough Therapy Drugs Market Share (2019-2020)
Table 66. India Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Breakthrough Therapy Drugs Market Share by Type (2015-2020)
Table 68. India Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Breakthrough Therapy Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Breakthrough Therapy Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Breakthrough Therapy Drugs Market Share (2019-2020)
Table 72. Central & South America Breakthrough Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Breakthrough Therapy Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Breakthrough Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Breakthrough Therapy Drugs Market Share by Application (2015-2020)
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Product
Table 79. Merck Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 80. Merck Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Product
Table 84. Pfizer Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 85. Pfizer Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Product
Table 89. AbbVie Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 90. AbbVie Recent Development
Table 91. Bristol-Myers Squibb Company Company Details
Table 92. Bristol-Myers Squibb Company Business Overview
Table 93. Bristol-Myers Squibb Company Product
Table 94. Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 95. Bristol-Myers Squibb Company Recent Development
Table 96. Genentech Company Details
Table 97. Genentech Business Overview
Table 98. Genentech Product
Table 99. Genentech Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 100. Genentech Recent Development
Table 101. Gilead Company Details
Table 102. Gilead Business Overview
Table 103. Gilead Product
Table 104. Gilead Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 105. Gilead Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Product
Table 109. Novartis Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 110. Novartis Recent Development
Table 111. Vertex Pharmaceuticals Incorporated Business Overview
Table 112. Vertex Pharmaceuticals Incorporated Product
Table 113. Vertex Pharmaceuticals Incorporated Company Details
Table 114. Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2015-2020) (Million US$)
Table 115. Vertex Pharmaceuticals Incorporated Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breakthrough Therapy Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. Anti-Viral Features
Figure 4. Neurology Features
Figure 5. Others Features
Figure 6. Global Breakthrough Therapy Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Services Case Studies
Figure 10. Breakthrough Therapy Drugs Report Years Considered
Figure 11. Global Breakthrough Therapy Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Breakthrough Therapy Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Breakthrough Therapy Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Breakthrough Therapy Drugs Market Share by Players in 2019
Figure 16. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Breakthrough Therapy Drugs Revenue in 2019
Figure 18. North America Breakthrough Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Breakthrough Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Breakthrough Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Breakthrough Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Breakthrough Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Breakthrough Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Breakthrough Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ウイルス性結膜炎治療薬の世界市場（～2026年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…- 理学療法サービスの世界市場（～2026年） Physical therapy is one of the allied health professions that, by using mechanical force and movements, manual therapy, exercise therapy, and electrotherapy, remediates impairments and promotes mobility and function. Physical therapy is used to improve a patient's quality of life through examination…
- スピーチセラピーサービスの世界市場（～2026年） Speech therapy services involves the treatment of communication and speech related disorders. North America is estimated to lead the global speech therapy services market due to rise in incidence of congenital disorders, increase in elderly population etc. Market Analysis and Insights: Global Speech…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- ウイルス性結膜炎パイプライン薬剤の世界市場（～2026年） Market Analysis and Insights: Global Viral Conjunctivitis Pipeline Drugs Market The global Viral Conjunctivitis Pipeline Drugs market size is projected to reach US$ 51 million by 2026, from US$ 36 million in 2020, at a CAGR of 39.5%% during 2021-2026. Global Viral Conjunctivitis Pipeline Drugs Scope…